| |
| |
|
| Insider
Information: |
Caligan Partners Lp |
| Relationship: |
See Remarks, Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
18,176 |
|
|
Indirect Shares
|
9,677,529 |
|
|
| Direct
Value |
$398,509 |
|
|
|
Indirect Value
|
$45,918,575 |
|
|
| Total
Shares |
9,695,705 |
|
|
| Total
Value |
$46,317,084 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
AMAG Pharmaceuticals Inc |
AMAG |
10% Owner |
2020-11-16 |
0 |
2020-11-16 |
0 |
Premium* |
|
|
Fluidigm Corp |
FLDM |
10% Owner |
2022-12-29 |
0 |
2022-12-29 |
8,576,799 |
Premium* |
|
|
Exelixis Inc |
EXEL |
See Remarks, Director |
2024-02-21 |
18,176 |
2024-02-21 |
1,100,730 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
7 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EXEL |
Exelixis Inc |
See Remarks |
– • – |
2024-02-21 |
4 |
B |
$20.70 |
$3,932,734 |
I/I |
190,000 |
1,100,730 |
2.1 |
% |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2023-11-27 |
4 |
S |
$21.61 |
$2,602,038 |
I/I |
(120,409) |
790,321 |
0 |
% |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2023-11-27 |
4 |
B |
$21.61 |
$2,602,038 |
I/I |
120,409 |
910,730 |
2.1 |
% |
|
| EXEL |
Exelixis Inc |
See Remarks |
– • – |
2023-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
18,176 |
18,176 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2023-05-31 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
910,730 |
|
% |
|
| FLDM |
Fluidigm Corp |
10% Owner |
– – • |
2022-12-29 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,868,037) |
8,576,799 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
10% Owner |
– – • |
2020-11-16 |
4 |
D |
$0.00 |
$0 |
I/I |
(3,499,428) |
0 |
0 |
- |
|
7 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
